About
Claudio Soto is a neuroscientist focused on neurodegenerative disease, protein misfolding, and diagnostic technologies for disorders such as Alzheimer's and Parkinson's disease. He is cofounder and Chief Scientific Officer of Amprion and also serves as a professor of neurology and research-center director at UTHealth/University of Texas McGovern Medical School in Houston. His profile fits best as a scientific and translational-research ecosystem influencer rather than a capital allocator.
Areas of interest
neurodegenerative diseasealzheimer's diseaseparkinson's diseaseprion biologyprotein misfoldingbiotech diagnosticsbiosensingtranslational neuroscience